Carolyn Welshhans

Carolyn Welshhans

Morgan Lewis

Contact
View Bio
RSS

Latest Posts › Biotechnology

Share:

SEC Focus on the Life Sciences Industry: What to Expect and How to Prepare

The life sciences sector remains a critical area of focus for the US Securities and Exchange Commission (SEC) under the current administration. Companies operating in the healthcare, pharmaceutical, biotechnology, and medical...more

6/9/2025  /  Biotechnology , Cybersecurity , Disclosure Requirements , Financial Fraud , Insider Trading , Life Sciences , Medical Devices , Pharmaceutical Industry , Regulation FD , Securities and Exchange Commission (SEC)
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide